Noa Zohar-Even

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

First case report of talquetamab use in AL amyloidosis.

First case report of talquetamab use in AL amyloidosis.

Journal: Leukemia & lymphoma

Published: October 16, 2025

Nivolumab for CNS relapsed refractory primary mediastinal B-cell lymphoma: case report and review of the literature.

Nivolumab for CNS relapsed refractory primary mediastinal B-cell lymphoma: case report and review of the literature.

Journal: Leukemia & lymphoma

Published: September 03, 2024

Prognostic Factors, FLT-3 Mutations, and Treatment Outcomes with Pediatric-Inspired Protocols in Adolescent and Young Adults and Adult Patients with Acute Lymphoblastic Leukemia.

Prognostic Factors, FLT-3 Mutations, and Treatment Outcomes with Pediatric-Inspired Protocols in Adolescent and Young Adults and Adult Patients with Acute Lymphoblastic Leukemia.

Journal: Acta haematologica

Published: July 07, 2024

Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of Interest.

Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of Interest.

Journal: Cancers

Published: October 11, 2023

The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia.

The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia.

Journal: International journal of molecular sciences

Published: August 30, 2022

Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center study.

Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center study.

Journal: Leukemia research

Published: May 02, 2022

CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival.

CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival.

Journal: Journal of clinical medicine

Published: April 15, 2022

Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma.

Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma.

Journal: Journal of clinical medicine

Published: February 16, 2022

Recognizing the unique prenatal phenotype of Prader-Willi Syndrome (PWS) indicates the need for a diagnostic methylation test.

Recognizing the unique prenatal phenotype of Prader-Willi Syndrome (PWS) indicates the need for a diagnostic methylation test.

Journal: Prenatal diagnosis

Published: January 05, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026